A new treatment for sexually-transmitted diseases seems to be slowing an STI epidemic — but not everyone can get it ...

Doxycycline postexposure prophylaxis (doxyPEP) initiation is associated with decreases in sexually transmitted infections (STIs).

Doxycycline postexposure prophylaxis has the potential to substantially reduce real-world population-level incidence of ...

The early rollout of doxyPEP — a dose of the antibiotic doxycycline after sex — has contributed to a decline in sexually ...

The rates of chlamydia and syphilis declined dramatically among individuals living with HIV who were prescribed doxycycline ...

While the use of PrEP has helped drop the rates of HIV infections, instances of syphilis and chlamydia among queer men have ...

Researchers have found in a new new study that Doxycycline post-exposure prophylaxis was effective strategy for reducing ...

A new study tracked thousands of gay men taking PrEP and DoxyPEP.  A new study tracked thousands of gay men taking PrEP and ...

"These findings suggest that doxyPEP may offer substantial benefits for reducing population-level STI transmission with broader implementation." HealthDay News — Doxycycline postexposure ...

Two new studies suggest that a dose of doxycycline taken within 3 days of unprotected sex is associated with significant ...

The researchers found that 19.5 percent were dispensed doxyPEP, which was associated with older age (mean age, 40.4 versus 39.8 years), longer HIV PrEP use (mean, 4.2 versus 3.4 years), and a ...